United Therapeutics Corp

+2.83 (+1.30%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)10.07B
Current PE15.96
Forward PE 13.07
2yr Forward PE 11.87
See more stats
Estimates Current Quarter
Revenue$491.5 Million
Adjusted EPS$4.27
See more estimates
10-Day MA$221.24
50-Day MA$229.13
200-Day MA$202.69
See more pivots

United Therapeutics Corp Stock, NASDAQ:UTHR

1040 Spring Street, Silver Spring, Maryland 20910
United States of America
Phone: +1.301.608.9292
Number of Employees: 965


United Therapeutics Corp. operates as a biotechnology company engaged in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. It is involved in the development of novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. The company was founded by Martine A. Rothblatt on June 26, 1996, and is headquartered in Silver Spring, MD.